Schlossman RL - Search Results

1

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma.

Richardson PG, Schlossman RL, Weller E, Hideshima T, Mitsiades C, Davies F, LeBlanc R, Catley LP, Doss D, Kelly K, McKenney M, Mechlowicz J, Freeman A, Deocampo R, Rich R, Ryoo JJ, Chauhan D, Balinski K, Zeldis J, Anderson KC. Richardson PG, et al. Among authors: schlossman rl. Blood. 2002 Nov 1;100(9):3063-7. doi: 10.1182/blood-2002-03-0996. Blood. 2002. PMID: 12384400 Free article. Clinical Trial.

2

Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma.

Seiden MV, Schlossman R, Andersen J, Freeman A, Robertson M, Soiffer R, Freedman A, Mauch P, Ritz J, Nadler L, et al. Seiden MV, et al. Leuk Lymphoma. 1995 Mar;17(1-2):87-93. doi: 10.3109/10428199509051707. Leuk Lymphoma. 1995. PMID: 7773166 Clinical Trial.

3

Platelet transfusion and alternatives to transfusion in patients with malignancy.

Vaickus L, Breitmeyer JB, Schlossman RL, Anderson KC. Vaickus L, et al. Among authors: schlossman rl. Stem Cells. 1995 Nov;13(6):588-96. doi: 10.1002/stem.5530130603. Stem Cells. 1995. PMID: 8590860 Review.

4

Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells.

Urashima M, Ogata A, Chauhan D, Hatziyanni M, Vidriales MB, Dedera DA, Schlossman RL, Anderson KC. Urashima M, et al. Among authors: schlossman rl. Blood. 1996 Mar 1;87(5):1928-38. Blood. 1996. PMID: 8634441 Free article.

5

Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein.

Urashima M, Ogata A, Chauhan D, Vidriales MB, Teoh G, Hoshi Y, Schlossman RL, DeCaprio JA, Anderson KC. Urashima M, et al. Among authors: schlossman rl. Blood. 1996 Sep 15;88(6):2219-27. Blood. 1996. PMID: 8822942 Free article.

6

Bone marrow transplantation in multiple myeloma.

Schlossman RL, Anderson KC. Schlossman RL, et al. Cancer Invest. 1997;15(1):65-75. doi: 10.3109/07357909709018919. Cancer Invest. 1997. PMID: 9028392 Review. No abstract available.

7

CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.

Soiffer RJ, Fairclough D, Robertson M, Alyea E, Anderson K, Freedman A, Bartlett-Pandite L, Fisher D, Schlossman RL, Stone R, Murray C, Freeman A, Marcus K, Mauch P, Nadler L, Ritz J. Soiffer RJ, et al. Among authors: schlossman rl. Blood. 1997 Apr 15;89(8):3039-47. Blood. 1997. PMID: 9108425 Free article. Clinical Trial.

8

Interleukin-6 overcomes p21WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon-gamma in multiple myeloma cells.

Urashima M, Teoh G, Chauhan D, Hoshi Y, Ogata A, Treon SP, Schlossman RL, Anderson KC. Urashima M, et al. Among authors: schlossman rl. Blood. 1997 Jul 1;90(1):279-89. Blood. 1997. PMID: 9207463 Free article.

9

CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.

Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J. Soiffer RJ, et al. Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7. Biol Blood Marrow Transplant. 1997. PMID: 9209736

10

IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.

Ogata A, Chauhan D, Teoh G, Treon SP, Urashima M, Schlossman RL, Anderson KC. Ogata A, et al. Among authors: schlossman rl. J Immunol. 1997 Sep 1;159(5):2212-21. J Immunol. 1997. PMID: 9278309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page